RA Capital Healthcare Fund LP
10% Owner; Director; Director, 10% Owner · 48 filings · Latest: Jun 29, 2026
Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Adicet Bio, Inc.
ARS Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Hemab Therapeutics Holdings, Inc.
Janux Therapeutics, Inc.
LENZ Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Nkarta, Inc.
Parabilis Medicines, Inc.
PepGen Inc.
Prelude Therapeutics Inc
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
Tyra Biosciences, Inc.
Vor Biopharma Inc.
Wave Life Sciences Ltd.
Werewolf Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
COAG | RA Capital Healthcare Fund LP | 10% Owner | May 12, 2026 | Purchase | $24.90 | 6,387 | $159.0K | 6,372,170 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | May 11, 2026 | Purchase | $11.52 | 6,510,416 | $75.0M | 15,203,995 | |
HOWL | RA Capital Healthcare Fund LP | 10% Owner | May 12, 2026 | Sale | $0.64 | 101,151 | $64.7K | 406,282 | |
HOWL | RA Capital Healthcare Fund LP | 10% Owner | May 11, 2026 | Sale | $0.67 | 87,490 | $58.6K | 413,001 | |
HOWL | RA Capital Healthcare Fund LP | 10% Owner | May 8, 2026 | Sale | $0.71 | 376,526 | $267.3K | 418,813 | |
COAG | RA Capital Healthcare Fund LP | 10% Owner | May 11, 2026 | Purchase | $24.81 | 39,869 | $989.2K | 6,365,783 | |
COAG | RA Capital Healthcare Fund LP | 10% Owner | May 8, 2026 | Purchase | $24.98 | 1,483 | $37.0K | 6,325,914 | |
COAG | RA Capital Healthcare Fund LP | 10% Owner | May 7, 2026 | Purchase | $24.46 | 9,906 | $242.3K | 6,324,431 | |
COAG | RA Capital Healthcare Fund LP | Director, 10% Owner | May 6, 2026 | Purchase | $24.60 | 68,018 | $1.7M | 6,314,525 | |
COAG | RA Capital Healthcare Fund LP | Director, 10% Owner | May 5, 2026 | Purchase | $24.63 | 97,411 | $2.4M | 6,246,507 | |
COAG | RA Capital Healthcare Fund LP | Director, 10% Owner | May 4, 2026 | Purchase | $18.00 | 2,675,000 | $48.1M | 354,938 | |
VOR | RA Capital Healthcare Fund LP | Director, 10% Owner | Apr 22, 2026 | Sale | $15.77 | 165,150 | $2.6M | 2,402,095 | |
VOR | RA Capital Healthcare Fund LP | Director, 10% Owner | Apr 20, 2026 | Sale | $15.77 | 171,963 | $2.7M | 2,567,245 | |
VOR | RA Capital Healthcare Fund LP | Director, 10% Owner | Apr 17, 2026 | Sale | $16.28 | 458,411 | $7.5M | 2,739,208 | |
VOR | RA Capital Healthcare Fund LP | Director, 10% Owner | Apr 15, 2026 | Sale | $16.01 | 53,644 | $858.8K | 3,197,619 | |
VOR | RA Capital Healthcare Fund LP | Director, 10% Owner | Apr 14, 2026 | Sale | $15.97 | 153,735 | $2.5M | 3,251,263 | |
VOR | RA Capital Healthcare Fund LP | Director, 10% Owner | Apr 13, 2026 | Sale | $16.15 | 530,610 | $8.6M | 3,404,998 | |
ACET | RA Capital Healthcare Fund LP | 10% Owner | Feb 20, 2026 | Purchase | $7.27 | 74,751 | $543.4K | 1,182,624 | |
ACET | RA Capital Healthcare Fund LP | 10% Owner | Feb 19, 2026 | Purchase | $7.21 | 74,268 | $535.5K | 1,107,873 | |
ACET | RA Capital Healthcare Fund LP | 10% Owner | Feb 18, 2026 | Purchase | $7.04 | 74,577 | $525.0K | 1,033,605 |